INTRAGEL’s novel technology features a pre-filled ready to use syringe which is for direct intra-tumoral application. The syringe contains an anti-cancer drug formulated into a de-novo gel-like, hydrophobic, biocompatible and biodegradable polymer that slowly releases the drug into the tumor over a few weeks with minimal systemic toxicity and maximum safety.